🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cardiovascular Risk Assessment

Twenty-four Hour Movement Behaviors and Atherosclerotic Risk NCT07774507n/a1 site📍 Presidente Prudente São Paulo State University Latvian Early Atherosclerosis Registry NCT06393894n/a1 site📍 Riga Pauls Stradins Clinical University Hospital · Tests: Near infrared spectroscopy, Genetic testing for LDLR, APOB, PCSK9 and LDLRAP1 mutations and niR-126, -145 and -155 expr… Akershus Cardiac Examination (ACE) 5 Study NCT07301489NA1 site📍 Lørenskog University Hospital, Akershus · Tests: Lung Cancer Screening Plus Program, Standard of Care COronoary Microcirculation Analysis NETwork NCT07498231NA1 site📍 Bialystok Medical University of Bialystok · Tests: Coronary microvascular function assessment, Coronary microvascular function assessment Risk of Falling and Cardiac Rehabilitation NCT06908759NA1 site📍 Rome IRCCS San Raffaele Roma · Tests: EXERCISE TRAINING WITH OR WITHOUT MEDICATION Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) NCT05712200Phase 3789 sites📍 Birmingham📍 Birmingham📍 Birmingham Anthos Therapeutics, Inc. · Tests: Abelacimab, Placebo Ambient Air and Noise Effect on Cardiovascular Health Risk and Lifestyle Intervention to Attenuate It (METSGREEN) NCT07111208NA2 sites📍 Kaunas📍 Kaunas Regina Grazuleviciene · Tests: Green Space Activity Group - Daily Physical Activity, Mediterranean Diet Group - Dietary Intervention Risk Evaluation and Management in Heart Failure NCT02998788n/a1 site📍 Shanghai Ruijin Hospital Coronary Artery Disease Assessment Strategies in TAVI Patients NCT06559332NA1 site📍 Bern Insel Gruppe AG, University Hospital Bern · Tests: Risk-based CAD management, Invasive coronary angiography NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study NCT06593327NA3 sites📍 Dallas📍 Dallas📍 Dallas University of Texas Southwestern Medical Center · Tests: Intensive Prevention Strategy Valveclip® Transcatheter Mitral Valve Repair Study NCT05021614NA1 site📍 Sichuan Shanghai NewMed Medical Co., Ltd. · Tests: Valveclip® Transcatheter mitral valve repair Evaluating Residual Congestion at Discharge in Acute Heart Failure Patients NCT06993220n/a1 site📍 Sant Joan Despí Consorci Sanitari Integral · Tests: Evaluation of residual congestion at discharge Cardiovascular Disease Prevention Strategies for High-risk Urban Sedentary Employees in Karachi, Pakistan NCT06981247NA1 site📍 Karachi Aga Khan University · Tests: m-LIfE: mobile based lifestyle intervention for employees to increase their physical activity and promote healthy diet.… Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus NCT07373938n/a1 site📍 Elche Cardenal Herrera University · Tests: SCORE2, SCORE2-Diabetes, Ultrasound Assessment The Efficacy Evaluation of Buckwheat Husk Extract on Cardiovascular Disease Risk Factors NCT04490720NA1 site📍 Taipei TCI Co., Ltd. · Tests: Placebo, Buckwheat husk extract Cardiovascular Risk Assessment and Coronary Calcium Score in Thai MASLD Patients NCT07865936n/a1 site📍 Bangkok Watcharasak Chotiyaputta Knowledge of Cardiovascular Risk Factors in Chronic Kidney Disease Patients NCT06674031n/a1 site📍 Ankara Hacettepe University Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease NCT07181109Phase 31190 sites📍 Birmingham📍 Birmingham📍 Fairhope Alnylam Pharmaceuticals · Tests: Zilebesiran, Placebo A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection. NCT07658534Phase 2, Phase 39 sites📍 Beijing📍 Guangzhou📍 Cangzhou Shanghai Ark Biopharmaceutical Co., Ltd. · Tests: Ziresovir (AK0529), Placebo Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations NCT06935513NA1 site📍 Nantong Affiliated Hospital of Nantong University · Tests: Wearable Devices Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin NCT06677060Phase 3977 sites📍 Birmingham📍 Centreville📍 Fairhope AstraZeneca · Tests: Baxdrostat and dapagliflozin, Placebo and dapagliflozin Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease NCT06930885Phase 313 sites📍 Maceió📍 Messejana📍 Petrolina Hospital do Coracao · Tests: Cardiovascular Polypill (Valsartan, Atorvastatin, Aspirin), Colchicine 0.5 mg, Usual Care Group, Colchicine-placebo 0.5… Mi-thos® Transcatheter Mitral Valve Replacement Study NCT04195984NA3 sites📍 Beijing📍 Shanghai📍 Xi’an Shanghai NewMed Medical Co., Ltd. · Tests: Mi-thos® valve and transapical delivery system SCAPIS 2 Cardio - Vibrometer Based Pulse Wave Analysis and CVD Risk Assessment NCT07001007n/a1 site📍 Stockholm HJN Sverige AB/Neko Health · Tests: Coronary Computer Tomography (CCTA), Laser Doppler Vibrometry and single-lead ECG, Echocardiography, Pulse Wave Velocity PRogression of Atheroma Evaluated by CT Angiography and IntraCoronary Imaging tEchniques NCT06794684n/a2 sites📍 Shanghai📍 Shanghai Ruijin Hospital Early Detection of Familial Hypercholesterolemia in Children NCT04370899n/a2 sites📍 Reus📍 Reus Institut Investigacio Sanitaria Pere Virgili · Tests: lifestyle assessment Future Optimal Research and Care Evaluation NCT03823547n/a4 sites📍 Apeldoorn📍 Arnhem📍 Ede J.M. ten Berg A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events NCT07448038Phase 225 sites📍 Beverly Hills📍 Beverly Hills📍 Irvine Genentech, Inc. · Tests: Selnoflast, Placebo Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38) NCT06535568NA1 site📍 Milan Fondazione Ricerca e Innovazione Cardiovascolare ETS · Tests: Drug-coated balloon, Single antiplatelet therapy (SAPT), Dual antiplatelet therapy (DAPT) A Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder NCT07206212NA1 site📍 Huddinge Karolinska Institutet · Tests: A group-based lifestyle intervention for individuals with OCD, Medical and lifestyle advice
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy